Illumina and DexCom raised or reaffirmed 2026 guidance after stronger-than-expected first-quarter results. Illumina beat revenue and earnings forecasts on robust clinical markets, product placements, ...

Dexcom () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smarter ...

SAN DIEGO (AP) — SAN DIEGO (AP) — DexCom Inc. (DXCM) on Thursday reported first-quarter earnings of $199.5 million. The San Diego-based company said it had profit of 51 cents per share. Earnings, ...

Dexcom posted first-quarter 2026 results ahead of Wall Street expectations, with revenue up 15% to $1.19 billion and adjusted EPS of $0.56. The company raised its operating and EBITDA margin outlooks ...

May 1 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab beat first-quarter sales estimates helped by strong demand for its continuous glucose monitors (CGMs) used by patients with ...

The company will unveil Dexcom Smart Basal*, a new integrated titration module designed to make basal insulin initiation and management easier† for users, which is currently under FDA and CE mark ...

Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ...

VIENNA--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in glucose biosensing, will present new product features and a compilation of new evidence that shows the benefits of its glucose ...